Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CACFD1 | gCSI | pan-cancer | AAC | -0.23 | 0.0004 |
mRNA | DLG5 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
mRNA | HAP1 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
mRNA | BMP1 | gCSI | pan-cancer | AAC | 0.23 | 0.0004 |
mRNA | ATP2B4 | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
mRNA | ADCY9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | COL18A1 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0004 |
mRNA | CACNA1S | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | GAK | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
mRNA | ASTN2 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |